Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate

scientific article published on 23 April 2013

Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/1055-9965.EPI-12-0965
P932PMC publication ID3696983
P698PubMed publication ID23613026

P2093author name stringDeliang Tang
Benjamin A Rybicki
Andrew Rundle
Michelle Jankowski
Oleksandr N Kryvenko
P2860cites workSocioeconomic status and obesity: A review of the literatureQ22251325
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005Q24656098
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsQ28131763
Obesity and prostate cancer: making sense out of apparently conflicting dataQ31111552
Trends and patterns of prostate cancer: what do they suggest?Q34093952
The role of increasing detection in the rising incidence of prostate cancerQ34293214
Human prostate cancer risk factorsQ34360616
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancerQ34716253
Effect of obesity on prostate-specific antigen, prostate volume, and international prostate symptom score in patients with benign prostatic hyperplasiaQ35070021
Socioeconomic status and weight change in adults: a reviewQ36060136
Are findings from studies of obesity and prostate cancer really in conflict?Q36367485
Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African AmericansQ36499803
Body size and composition and prostate cancer risk: systematic review and meta-regression analysisQ36577688
Racial differences in risk of prostate cancer associated with metabolic syndromeQ37248315
Personal and neighborhood socioeconomic status and indices of neighborhood walk-ability predict body mass index in New York City.Q37326379
Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysisQ37375062
Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.Q37509632
Ductal carcinoma in situ: risk factors and impact of screening.Q37509637
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancerQ37851004
Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studiesQ37974152
Body mass index as a predictor of prostate cancer: development versus detection on biopsyQ39722183
Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinicQ39833969
Interpreting precursor studies: what polyp trials tell us about large-bowel cancerQ40557445
Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer.Q41532950
The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detectionQ41811446
Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.Q43421699
Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States.Q45110835
Obesity and prostate cancer screening among African-American and Caucasian men.Q46157341
Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detectionQ46890162
The income divide in health care: how the Affordable Care Act will help restore fairness to the U.S. health systemQ48800746
County-level poverty and distant stage cancer in the United StatesQ50110882
Obesity and screening PSA levels among men undergoing an annual physical exam.Q51112448
Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets.Q53255823
Anthropometric Factors in Adulthood and Risk of Colorectal Adenomas: The French E3N-EPIC Prospective CohortQ53295101
Obesity and prostate cancer screening in the USAQ57314343
Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention TrialQ58394513
Prostate cancer epidemiologyQ73138981
Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasiaQ79864112
P433issue5
P921main subjectobesityQ12174
prostate cancerQ181257
P304page(s)898-904
P577publication date2013-04-23
P1433published inCancer Epidemiology, Biomarkers & PreventionQ326334
P1476titleObesity and future prostate cancer risk among men after an initial benign biopsy of the prostate
P478volume22